The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tislelizumab plus tyrosine kinase inhibitor versus active surveillance in patients with ablated high-risk hepatocellular carcinoma: An open-label, parallel controlled, prospective cohort study.
 
Shida Pan
No Relationships to Disclose
 
Siyu Wang
No Relationships to Disclose
 
Jiahe Tian
No Relationships to Disclose
 
Yingjuan Shen
No Relationships to Disclose
 
Luo Yang
No Relationships to Disclose
 
Xiaomeng Liu
No Relationships to Disclose
 
Yingying Yu
No Relationships to Disclose
 
Yilin Wang
No Relationships to Disclose
 
Qin Qiu
No Relationships to Disclose
 
Junqing Luan
No Relationships to Disclose
 
Xing Fan
No Relationships to Disclose
 
Fanping Meng
No Relationships to Disclose